News

Popper and Co. to Present New Framework for Economic Evaluation of Diagnostics in the Era of Precision Medicine at Next Generation Dx Summit

Popper

Popper and Co., a strategy consulting and transaction advisory firm serving the needs of the medical technology and life sciences industries, announced today that Co-Founder and President Caroline Popper, M.D., will speak at the 10th Annual Next Generation Dx Summit on August 22 at 5 pm ET at the Grand Hyatt Washington in Washington, DC. In the era of precision medicine, it’s more important […]

Comments Off on Popper and Co. to Present New Framework for Economic Evaluation of Diagnostics in the Era of Precision Medicine at Next Generation Dx Summit Continue Reading →

Paragon Bioservices Announces Two Key Leadership Promotions

Paragon

BALTIMORE, MD, August 8, 2018 – Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, announces today two key leadership promotions. Deborah Wild has been promoted from Vice President, Quality, Validation and Regulatory Affairs to Senior Vice President, Quality, Validation and Regulatory Affairs, […]

Comments Off on Paragon Bioservices Announces Two Key Leadership Promotions Continue Reading →

Paragon Bioservices Recognized as Life Science Company of the Year by MTC

Paragon

Baltimore, MD, May 18, 2018 – Paragon Bioservices, Inc. (Paragon), the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, was named the 2018 Life Science Company of the Year by the Maryland Tech Council (MTC). The announcement came at MTC’s 30th Annual Industry Awards held last night […]

Comments Off on Paragon Bioservices Recognized as Life Science Company of the Year by MTC Continue Reading →

UMB’s Jim Hughes Featured in BioTalk Podcast: Live from the BioHealth Capital Region Forum

BIoTalk Logo_small

During the BioHealth Capital Region Forum held last month, Jim Hughes, Vice President at University of Maryland, Baltimore, was among those interviewed for a BioTalk Podcast including select leaders from different parts of the BioHealth Capital Region discussing what they are working on, and their thoughts on the event. Jim discussed some of the recent startup successes […]

Comments Off on UMB’s Jim Hughes Featured in BioTalk Podcast: Live from the BioHealth Capital Region Forum Continue Reading →

WellDoc’s Digital Platform for Type 2 Diabetes Powers “Diabetes Wellness Program” Within Samsung Health

WellDoc

Program Available on U.S.-Based Samsung Galaxy Devices Designed to Support a Healthy Lifestyle for Individuals Living with Type 2 Diabetes MOUNTAIN VIEW, CALIF., AND COLUMBIA, MARYLAND – MARCH 6, 2018 – Samsung Electronics America, Inc. and WellDoc®, a leading digital therapeutic company, announced today that Samsung Health users now have access to a new consumer version of WellDoc’s digital […]

Comments Off on WellDoc’s Digital Platform for Type 2 Diabetes Powers “Diabetes Wellness Program” Within Samsung Health Continue Reading →

Viela Bio Spins Out of MedImmune

vielabio-logo-blue

Viela Bio Spins Out of MedImmune; Launches with Up to $250 Million Series A Financing from Investor Consortium Led by Boyu Capital, 6 Dimensions Capital, and Hillhouse Capital Viela Bio team will focus on developing medicines for severe autoimmune diseases by targeting critical pathways that are the root cause of disease Gaithersburg, MD, February 28, 2018 – Viela Bio […]

GlycoMimetics, Inc. Co-Founder & CEO Rachel K. King Interviewed on New Episode of BHI Podcast – BioTalk with Rich Bendis

MVIMG_20180215_144308 square

Rachel K. King, Co-Founder and CEO, GlycoMimetics, Inc. (GMI), joins Rich Bendis for the latest episode of BioTalk. They cover topics from her background in the industry to running a publicly traded company in the BioHealth Capital Region. Before founding GMI, she was an Executive in Residence at New Enterprise Associates (NEA), one of the […]

Comments Off on GlycoMimetics, Inc. Co-Founder & CEO Rachel K. King Interviewed on New Episode of BHI Podcast – BioTalk with Rich Bendis Continue Reading →

Technical.ly Baltimore: Where Steve Case sees opportunity for Baltimore’s startup community

AnchorVentures-LinkedIn-ProfilePhoto

At this point, Steve Case has seen many startup communities, as his Rise of the Rest bus tour has been to 33 cities. Speaking Thursday at Johns Hopkins’ FastForward 1812 in East Baltimore on Thursday night, the AOL cofounder said each community has a unique story and opportunity for growth. As far as the prospects for Baltimore, he pointed to increasing work […]

Comments Off on Technical.ly Baltimore: Where Steve Case sees opportunity for Baltimore’s startup community Continue Reading →

HopeWell Cancer Support Announces Concert for Hope 12 Featuring The Bridge at Baltimore Soundstage on Feb 10, 2018

hopewell

Concert For Hope 12 at Baltimore Soundstage Saturday 2/10/2018! A Benefit For HopeWell Cancer Support Featuring Batlimore’s own THE BRIDGE and Bootleg – Kick up your heels! Tickets: $125 VIP in advance // $135 VIP at the door (if available) $25 GA in advance // $35 at the door (if available) Each ticket purchase goes […]

Comments Off on HopeWell Cancer Support Announces Concert for Hope 12 Featuring The Bridge at Baltimore Soundstage on Feb 10, 2018 Continue Reading →

IQVIA Institute Rates WellDoc’s BlueStar® as “Top App” in Clinical Diabetes Treatment

WellDoc

COLUMBIA, Md., Nov. 13, 2017 (GLOBE NEWSWIRE) — WellDoc®, a leading digital health company, announced today that IQVIA Institute for Human Data Science (formerly Quintiles/IMS) named BlueStar®, WellDoc’s FDA-cleared, proven digital therapeutic for people living with type 2 diabetes, the “top app” in the category of clinical diabetes treatment. The related report entitled, “The Growing Value of […]

Comments Off on IQVIA Institute Rates WellDoc’s BlueStar® as “Top App” in Clinical Diabetes Treatment Continue Reading →